Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Horizant for Alcohol Use Disorder
NCT02252536Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jun 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin enacarbil in alcohol use disorder (AUD), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Jun 2015; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02252536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252536.